Patent ID: 11939370
Assignee: VANDERBILT UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 0:
1. A method of treating a subject infected with ebolavirus, or reducing the likelihood of infection of a subject at risk of contracting ebolavirus, comprising administering to said subject an antibody or antibody fragment having clone-paired heavy and light chain CDR sequences selected from heavy chain CDR1-3 of SEQ ID NOS: 91, 92 and 93, and light chain CDR1-3 of SEQ ID NOS: 154, 155, and 156; heavy chain CDR1-3 of SEQ ID NOS: 118, 119 and 120, and light chain CDR1-3 of SEQ ID NOS: 181, 182, and 183; or heavy chain CDR1-3 of SEQ ID NOS: 127, 128 and 129, and light chain CDR1-3 of SEQ ID NOS: 190, 191, and 192.